Physical performance and glycemic control under SGLT-2-inhibitors in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH): Design of a 4-week prospective observational study

BACKGROUND: Type 2 diabetes (T2D) is associated with limitation in physical performance. Results from animal studies report enhancement of physical performance in T2D rodents treated with sodium glucose cotransporter 2 inhibitors (SGLT2is). However, in human patients with T2D and established atheros...

Descripción completa

Detalles Bibliográficos
Autores principales: Frundi, Devine S., Kettig, Eva, Popp, Lena Luise, Hoffman, Melanie, Dumartin, Marine, Hughes, Magali, Lamy, Edgar, Fru, Yvonne Joko Walburga, Bano, Arjola, Muka, Taulant, Wilhelm, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354468/
https://www.ncbi.nlm.nih.gov/pubmed/35935634
http://dx.doi.org/10.3389/fcvm.2022.907385

Ejemplares similares

Ejemplares similares